Total Payments
$12,742
2024 Payments
$1,156
Companies
35
Transactions
724
Medicare Patients
203
Medicare Billing
$22,152
Payment Breakdown by Category
Food & Beverage$12,723 (99.8%)
Education$19.35 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,723 | 721 | 99.8% |
| Education | $19.35 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,053 | 150 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,820 | 88 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,297 | 88 | $0 (2024) |
| Lilly USA, LLC | $1,127 | 68 | $0 (2024) |
| PFIZER INC. | $847.98 | 49 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $644.54 | 42 | $0 (2024) |
| Allergan, Inc. | $551.16 | 54 | $0 (2020) |
| ABBVIE INC. | $526.56 | 32 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $426.19 | 24 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $337.97 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,156 | 60 | GlaxoSmithKline, LLC. ($202.05) |
| 2023 | $1,520 | 77 | GlaxoSmithKline, LLC. ($349.30) |
| 2022 | $1,630 | 89 | GlaxoSmithKline, LLC. ($306.43) |
| 2021 | $2,320 | 135 | Novo Nordisk Inc ($779.11) |
| 2020 | $1,157 | 67 | Novo Nordisk Inc ($522.15) |
| 2019 | $1,837 | 102 | AstraZeneca Pharmaceuticals LP ($527.30) |
| 2018 | $1,780 | 102 | Novo Nordisk Inc ($670.81) |
| 2017 | $1,342 | 92 | Lilly USA, LLC ($318.49) |
All Payment Transactions
724 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Endocrinology | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Endocrinology | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 52 | 94 | $8,198 | $5,043 |
| 2022 | 1 | 29 | 71 | $6,375 | $3,768 |
| 2021 | 2 | 69 | 121 | $11,520 | $8,554 |
| 2020 | 1 | 53 | 121 | $9,432 | $4,787 |
Total Patients
203
Total Services
407
Medicare Billing
$22,152
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 69 | $6,279 | $3,267 | 52.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $1,703 | $1,573 | 92.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $215.52 | $203.16 | 94.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 71 | $6,375 | $3,768 | 59.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 99 | $8,935 | $5,969 | 66.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 22 | 22 | $2,585 | $2,585 | 100.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 53 | 121 | $9,432 | $4,787 | 50.8% |
About Dr. Sasha Pagan, MD
Dr. Sasha Pagan, MD is a General Practice healthcare provider based in Kissimmee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124236773.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sasha Pagan, MD has received a total of $12,742 in payments from pharmaceutical and medical device companies, with $1,156 received in 2024. These payments were reported across 724 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($12,723).
As a Medicare-enrolled provider, Pagan has provided services to 203 Medicare beneficiaries, totaling 407 services with total Medicare billing of $22,152. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Kissimmee, FL
- Active Since 05/18/2007
- Last Updated 06/27/2013
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1124236773
Products in Payments
- Ozempic (Drug) $1,386
- FARXIGA (Drug) $1,097
- TRELEGY ELLIPTA (Drug) $975.32
- JARDIANCE (Drug) $940.33
- RYBELSUS (Drug) $743.80
- VRAYLAR (Drug) $542.29
- TRULICITY (Drug) $356.71
- Tresiba (Drug) $346.11
- Kerendia (Drug) $337.97
- BREZTRI (Drug) $260.94
- XARELTO (Drug) $258.92
- LYRICA (Drug) $255.16
- UBRELVY (Drug) $227.94
- Rybelsus (Drug) $223.49
- NURTEC ODT (Drug) $212.48
- SYMBICORT (Drug) $196.86
- Vascepa (Drug) $192.85
- ELIQUIS (Drug) $185.25
- JANUVIA (Drug) $184.86
- MOUNJARO (Drug) $174.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Kissimmee
Dr. Miguel Melendez Munoz, M.d, M.D
General Practice — Payments: $22,114
General Practice $22,114
Dr. Juan Fernandez- Maceiro, M.d, M.D
General Practice — Payments: $12,282
General Practice $12,282
Dr. Jose Serrano, M.d, M.D
General Practice — Payments: $9,694
General Practice $9,694
Norma Perez - Torres, M.d, M.D
General Practice — Payments: $8,253
General Practice $8,253
Wanda Berrios, Md, MD
General Practice — Payments: $5,777
General Practice $5,777
Gretchen Rodriguez, M.d, M.D
General Practice — Payments: $5,554
General Practice $5,554